CLEVELAND -- One of the largest makers of generic opioids has settled a lawsuit with two Ohio counties, removing the company from the first federal trial over the toll of the opioid crisis.
United Kingdom-based Mallinckrodt announced the deal with Cuyahoga and Summit counties on Friday. Under the settlement, the company would pay a total of $24 million and donate products, including some used to treat addiction, worth another $6 million.
The company's general counsel said in a statement that resolving the first cases gives it time to work toward a "global resolution" of opioid lawsuits. Nearly every state in the U.S. and more than 2,000 local governments are suing drug companies over the crisis. Mallinckrodt remains a defendant in hundreds of those cases.
The deal makes Mallinckrodt the third company in recent weeks to announce a deal with the two counties ahead of the trial, scheduled to begin Oct. 21 in U.S. District Court in Cleveland. Allergan agreed to pay $5 million and Endo Pharmaceuticals $10 million.
Perhaps the best-known manufacturer of prescription opioids, OxyContin maker Purdue Pharma, is negotiating in an attempt to settle all the claims against it.